Diagnostic and treatment algorithms incorporated predictive values of Galectin-3 (Gal-3) and interleukin-33 (IL-33) in treatment of coronary diseases and heart failure (5, 6) and evaluating prediabetic state (7). Here, LGALS3 is linked to heart failure.